Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 4 records, 1 pages
Search For: Adeno-Associated Virus (AAV) Vector-Based Gene Therapy
Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Supply, Demand and Key Producers, 2024-2030
29 Feb 2024
Pharma & Healthcare
Adeno-Associated Virus (AAV) Vector-Based Gene Therapy
The global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy market size is expected to reach $ 1123 million by 2030, rising at a market growth of 5.2% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030
04 Jan 2024
Pharma & Healthcare
Adeno-Associated Virus (AAV) Vector-Based Gene Therapy
According to our (Global Info Research) latest study, the global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy market size was valued at USD 789.2 million in 2023 and is forecast to a readjusted size of USD 1123 million by 2030 with a CAGR of 5.2% during review period.
USD3480.00
Add To Cart
Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Supply, Demand and Key Producers, 2023-2029
23 Jan 2023
Pharma & Healthcare
Adeno-Associated Virus (AAV) Vector-Based Gene Therapy
The global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029
10 Jan 2023
Pharma & Healthcare
Adeno-Associated Virus (AAV) Vector-Based Gene Therapy
AAV is transformed from a naturally occurring virus into a delivery mechanism for gene therapy. The viral DNA is replaced with new DNA, and it becomes a precisely coded vector and is no longer considered a virus, as most of the viral components have been replaced. The AAV Vector-Based Gene Therapy market size is anticipated to shoot up exponentially attributing to an increase in the approval of a growing number of gene therapies and readily adoption on approval, ability to treat a broad array of conditions, increasing prevalence of diseases, convenient one-time dosing approach and curative treatment options.
USD3480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Adeno-Associated Virus (AAV) Vector-Based Gene Therapy
Total: 4 records, 1 pages
The global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy market size is expected to reach $ 1123 million by 2030, rising at a market growth of 5.2% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy market size was valued at USD 789.2 million in 2023 and is forecast to a readjusted size of USD 1123 million by 2030 with a CAGR of 5.2% during review period.
USD3480.00
Add To Cart
The global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
AAV is transformed from a naturally occurring virus into a delivery mechanism for gene therapy. The viral DNA is replaced with new DNA, and it becomes a precisely coded vector and is no longer considered a virus, as most of the viral components have been replaced. The AAV Vector-Based Gene Therapy market size is anticipated to shoot up exponentially attributing to an increase in the approval of a growing number of gene therapies and readily adoption on approval, ability to treat a broad array of conditions, increasing prevalence of diseases, convenient one-time dosing approach and curative treatment options.
USD3480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>